Opportunity Information: Apply for CDC RFA GH16 1668
Apply for CDC RFA GH16 1668
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Implementing Comprehensive Community Based HIV/AIDS Prevention, Care and Treatment Services in Priority Areas in the Republic of Zambia under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Dec 08, 2015 and posted on Dec 08, 2015.
- Applicants must submit their applications by Feb 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Implementing Comprehensive Community Based HIV/AIDS Prevention, Care and Treatment Services in Priority Areas in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. Centers for Disease Control and Prevention (CDC) cooperative agreement designed to strengthen Zambia's HIV response through comprehensive, community-based services. The central aim is to deliver a combination package of HIV prevention, care, and treatment interventions for high-priority populations in targeted geographic areas, with a strong emphasis on connecting community activities to facility-based services within priority districts. In practical terms, the program is meant to help identify people at risk or living with HIV, ensure they are effectively linked into the health system, and keep them engaged in care, including long-term treatment adherence support for individuals on antiretroviral therapy (ART).
A key feature of the opportunity is its focus on integrated, community-driven approaches that complement clinical services rather than operating separately from them. The funded work is expected to support timely linkage to health facilities, meaning people reached in community settings should be guided and supported to access testing, clinical evaluation, ART initiation when eligible, and ongoing follow-up at health facilities in the targeted districts. Another major component is adherence support for people already on ART, which typically includes community follow-up, counseling, treatment literacy, retention support, and addressing barriers that lead to missed appointments or treatment interruptions. The overall intention is to improve outcomes across the HIV service continuum, from prevention and identification through sustained viral suppression.
The opportunity also explicitly frames the work as supporting the Zambian government's national HIV/AIDS response and building on existing systems rather than creating parallel ones. The awardee is expected to work in ways that reinforce what is already in place and extend it where gaps remain, especially for populations and areas considered high priority. A strong sustainability and transition expectation runs through the description: the recipient must build the capacity of district health teams and local facility teams so that program functions can be maintained over time, with an intentional shift of ownership and implementation to Government of Zambia district and facility structures as the project matures. This implies ongoing mentoring, systems strengthening, and operational support that leaves behind skills, processes, and coordination mechanisms that can continue after external funding reduces or ends.
Administratively, the award is offered as a discretionary cooperative agreement, meaning CDC is expected to have substantial involvement in the program beyond standard grant oversight, such as technical collaboration, guidance on implementation strategies, performance monitoring expectations, and alignment with PEPFAR priorities. The funding opportunity number is CDC RFA GH16-1668, and it is listed under the health funding activity category with CFDA number 93.067. The anticipated project structure includes a single awardee (Expected Awards: 1), with an award ceiling of $2,500,000. The opportunity was created and posted on December 8, 2015, and the closing date for applications was February 8, 2016.
Eligibility is broadly categorized as "Others," with clarification referenced in an additional eligibility text field not included in the provided excerpt. In general, that phrasing often indicates that eligibility may extend beyond traditional categories and could include certain non-profit organizations, academic institutions, or other entities permitted under the full announcement, but the precise eligible applicant types would need to be confirmed in the complete FOA.
Overall, the grant is aimed at measurable, district-focused impact: expanding and improving community-based combination HIV prevention, ensuring strong linkage to clinical care, supporting adherence and retention for people on ART, and strengthening district health capacity so the work can be sustained and eventually transitioned to Zambia's local health teams.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Implementing Comprehensive Community Based HIV/AIDS Prevention, Care and Treatment Services in Priority Areas in the Republic of Zambia under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which U.S. agency is offering this award?
This is a U.S. Centers for Disease Control and Prevention (CDC) funding opportunity offered as a cooperative agreement.
What type of award is this?
It is a discretionary cooperative agreement, which typically means CDC expects to be substantially involved beyond standard grant monitoring (for example, through technical collaboration, implementation guidance, and performance monitoring expectations aligned with PEPFAR priorities).
What is the main goal of the program?
The central aim is to strengthen Zambia's HIV response by delivering a comprehensive, community-based package of HIV prevention, care, and treatment services in targeted, high-priority geographic areas, with strong connections between community activities and facility-based services within priority districts.
Where will the work take place?
The work is intended for priority areas in the Republic of Zambia, focused on targeted geographic areas and priority districts.
What populations are intended to be served?
The opportunity emphasizes reaching high-priority populations in targeted geographic areas, including people at risk of HIV and people living with HIV, particularly those needing linkage to services and long-term support to remain engaged in care.
What is meant by a "combination package" of HIV services?
In this opportunity, a combination package refers to integrated HIV prevention, care, and treatment interventions delivered through community-based approaches, designed to complement facility-based clinical services and improve outcomes across the HIV service continuum.
How does the opportunity expect community activities to connect with health facilities?
The funded work is expected to support timely linkage to health facilities. People reached in community settings should be guided and supported to access facility services such as testing, clinical evaluation, ART initiation when eligible, and ongoing follow-up in the targeted districts.
Does this program include HIV testing and linkage to ART?
The description highlights identifying people at risk or living with HIV and ensuring they are effectively linked into the health system, including access to testing, clinical evaluation, and ART initiation when eligible, followed by ongoing engagement in care.
What role does adherence and retention support play in this program?
Adherence support is a major component. The program is expected to provide long-term treatment adherence support for individuals on antiretroviral therapy (ART), including community follow-up, counseling, treatment literacy, retention support, and addressing barriers that lead to missed appointments or treatment interruptions.
What outcomes is the program trying to improve?
The overall intention is to improve outcomes across the HIV service continuum, from prevention and identification through sustained engagement in care and viral suppression.
Is the program expected to create new systems, or build on existing ones?
The opportunity explicitly frames the work as supporting the Zambian government's national HIV/AIDS response and building on existing systems rather than creating parallel systems.
What does "sustainability and transition" mean in this opportunity?
There is a strong expectation that the recipient will build capacity within district health teams and local facility teams so program functions can be maintained over time, with intentional transition of ownership and implementation to Government of Zambia district and facility structures as the project matures.
What kind of capacity building is implied?
The description suggests ongoing mentoring, systems strengthening, and operational support that leaves behind skills, processes, and coordination mechanisms that can continue after external funding decreases or ends.
How many awards does CDC expect to make?
The opportunity anticipates a single awardee (Expected Awards: 1).
What is the maximum funding amount mentioned?
The award ceiling listed is $2,500,000.
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH16-1668.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.067.
When was this opportunity posted, and when did it close?
The opportunity was created and posted on December 8, 2015, and the closing date for applications was February 8, 2016.
Who is eligible to apply?
Eligibility is categorized as "Others," with clarification referenced in an additional eligibility text field that is not included in the provided excerpt. Based on the excerpt alone, the precise eligible applicant types cannot be confirmed without the complete funding announcement.
How involved will CDC be during implementation?
Because this is a cooperative agreement, CDC is expected to have substantial involvement, which can include technical collaboration, guidance on implementation strategies, performance monitoring expectations, and alignment with PEPFAR priorities.
How does this opportunity relate to PEPFAR?
The opportunity is explicitly positioned under the President's Emergency Plan for AIDS Relief (PEPFAR) and is designed to strengthen HIV prevention, care, and treatment programming in Zambia consistent with PEPFAR priorities.
What is the overall emphasis of the program design?
The emphasis is on district-focused, community-driven approaches that complement clinical services, strengthen linkage between community and facilities, improve adherence and retention for people on ART, and build district and facility capacity to sustain and eventually transition the work to local health structures.
Browse more opportunities from the same agency: HHS-CDC-CGH
Browse more opportunities from the same category: Health
Next opportunity: Service, Manufacturing and Operations Research
Previous opportunity: U.S. Ambassador’s Special Self-Help Fund 2015-2016, U.S. Embassy Lilongwe
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1668
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1668) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cooperative Agreements for Adolescent and Transitional Aged Youth Treatment Implementation [Youth Treatment – Implementation (Short Title –YT-I)] Apply for TI 16 006 Funding Number: TI 16 006 Agency: HHS-SAMHS Category: Health Funding Amount: $800,000 |
| Scholarships for Disadvantaged Students (SDS) Apply for HRSA 16 069 Funding Number: HRSA 16 069 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Early HIV Treatment to Optimize Patient Health and HIV Prevention Apply for RFA PS 16 006 Funding Number: RFA PS 16 006 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $495,000 |
| Academic Units for Primary Care Training and Enhancement Apply for HRSA 16 041 Funding Number: HRSA 16 041 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp) Apply for PA 16 013 Funding Number: PA 16 013 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Western Region and Turkana County of the Republic of Kenya under the President’s Emergency Plan for AIDS R Apply for CDC RFA GH16 1619 Funding Number: CDC RFA GH16 1619 Agency: HHS-CDC-CGH Category: Health Funding Amount: $103,000,000 |
| NHLBI Clinical Trial Pilot Studies (R34) Apply for PAR 16 037 Funding Number: PAR 16 037 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Pulmonary and Cardiovascular Consequences of Inhaled Nicotine (R01) Apply for RFA HL 17 008 Funding Number: RFA HL 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States Apply for RFA CK 16 005 Funding Number: RFA CK 16 005 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| Novel Genomic Technology Development Direct to Phase II SBIR (R44) Apply for PAR 16 017 Funding Number: PAR 16 017 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10) Apply for PAR 16 053 Funding Number: PAR 16 053 Agency: HHS-NIH11 Category: Health Funding Amount: $2,000,000 |
| Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific Apply for RFA IP 16 001 Funding Number: RFA IP 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $3,000,000 |
| Supporting the National Blood Transfusion Service (NBTS) in the implementation and strengthening of Blood Safety activities in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10260501SUPP16 Funding Number: CDC RFA PS10 10260501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $927,809 |
| National Child Traumatic Stress Initiative – Category III Community Treatment and Services (CTS) Centers Apply for SM 16 005 Funding Number: SM 16 005 Agency: HHS-SAMHS Category: Health Funding Amount: $400,000 |
| Implementation of Programs to Support Integration of Health Information Systems and HIV/AIDS/TB Treatment Services in the Republic of Zambia under the President’s Emergency Plan for AIDS (PEPFAR) Apply for CDC RFA GH16 1669 Funding Number: CDC RFA GH16 1669 Agency: HHS-CDC-CGH Category: Health Funding Amount: $10,000,000 |
| Enhanced surveillance in the Republic of Uganda under the President’s Emergency Plan for AIDS relief (PEPFAR) Apply for CDC RFA GH11 116505CONT16 Funding Number: CDC RFA GH11 116505CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Supporting the Scale up of Comprehensive HIV/AIDS Prevention Services in the Republic of Uganda under PEPFAR Apply for CDC RFA PS10 10200501SUPP16 Funding Number: CDC RFA PS10 10200501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $1,562,149 |
| Leadership Education in Neurodevelopmental and Other Related Disabilities (LEND) Apply for HRSA 16 031 Funding Number: HRSA 16 031 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Precision Medicine Initiative Cohort Program Biobank (U24) Apply for RFA PM 16 004 Funding Number: RFA PM 16 004 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Strengthening Community-Based HIV/AIDS Prevention and Care Services in the Underserved Northern and Western Regions of the Republic of Côte d’Ivoire Under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10330501SUPP16 Funding Number: CDC RFA PS10 10330501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $3,470,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1668", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.